By silencing or activating target proteins, EZH2 is involved in many links of cancer tumorigenesis and development, such as cell proliferation, epithelial–mesenchymal transition, invasion, and drug resistance of cancer cells, making it an important biomarker for cancer therapy. Here, EZH2 is linked to cancer.